Oppenheimer & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.62M Buy
54,209
+9,968
+23% +$888K 0.06% 352
2025
Q4
$3.5M Sell
44,241
-5,369
-11% -$421K 0.05% 383
2025
Q3
$3.97M Sell
49,610
-773
-2% -$65.9K 0.05% 395
2025
Q2
$4.58M Sell
50,383
-532
-1% -$48.6K 0.06% 336
2025
Q1
$4.77M Buy
50,915
+12,646
+33% +$1.13M 0.07% 303
2024
Q4
$3.48M Buy
38,269
+1,551
+4% +$148K 0.05% 376
2024
Q3
$3.81M Buy
36,718
+1,501
+4% +$153K 0.06% 349
2024
Q2
$3.42M Sell
35,217
-609
-2% -$56.2K 0.05% 366
2024
Q1
$3.23M Sell
35,826
-10,402
-23% -$881K 0.05% 378
2023
Q4
$3.68M Buy
46,228
+14
+0% +$1.05K 0.07% 327
2023
Q3
$3.29M Buy
46,214
+751
+2% +$56.2K 0.07% 326
2023
Q2
$3.5M Buy
45,463
+239
+0.5% +$18.5K 0.07% 309
2023
Q1
$3.4M Buy
45,224
+939
+2% +$69.8K 0.07% 305
2022
Q4
$3.49M Sell
44,285
-469
-1% -$35.2K 0.08% 296
2022
Q3
$3.14M Sell
44,754
-4,387
-9% -$344K 0.07% 319
2022
Q2
$3.94M Sell
49,141
-8,867
-15% -$693K 0.08% 277
2022
Q1
$4.4M Buy
58,008
+2,478
+4% +$196K 0.08% 296
2021
Q4
$4.74M Buy
55,530
+3,418
+7% +$267K 0.08% 281
2021
Q3
$3.94M Sell
52,112
-1,722
-3% -$137K 0.07% 315
2021
Q2
$4.38M Sell
53,834
-908
-2% -$74.2K 0.08% 293
2021
Q1
$4.32M Sell
54,742
-3,889
-7% -$305K 0.09% 277
2020
Q4
$5.01M Buy
58,631
+569
+1% +$47.1K 0.11% 221
2020
Q3
$4.48M Sell
58,062
-3,460
-6% -$264K 0.11% 208
2020
Q2
$4.51M Buy
61,522
+10,675
+21% +$758K 0.12% 194
2020
Q1
$3.37M Sell
50,847
-1,765
-3% -$124K 0.1% 209
2019
Q4
$3.62M Sell
52,612
-3,408
-6% -$232K 0.09% 262
2019
Q3
$4.12M Sell
56,020
-11,533
-17% -$837K 0.11% 206
2019
Q2
$4.84M Sell
67,553
-2,687
-4% -$191K 0.13% 179
2019
Q1
$4.81M Buy
70,240
+12,459
+22% +$805K 0.13% 176
2018
Q4
$3.44M Sell
57,781
-1,218
-2% -$76.2K 0.11% 210
2018
Q3
$3.95M Sell
58,999
-1,038
-2% -$69.1K 0.1% 227
2018
Q2
$3.89M Sell
60,037
-8,968
-13% -$587K 0.11% 219
2018
Q1
$4.95M Sell
69,005
-14,365
-17% -$1.03M 0.13% 176
2017
Q4
$6.29M Buy
83,370
+19,536
+31% +$1.43M 0.16% 141
2017
Q3
$4.65M Buy
63,834
+1,306
+2% +$94.1K 0.12% 191
2017
Q2
$4.63M Buy
62,528
+6,713
+12% +$498K 0.13% 192
2017
Q1
$4.09M Buy
55,815
+1,175
+2% +$82.2K 0.12% 216
2016
Q4
$3.58M Sell
54,640
-546
-1% -$37.4K 0.1% 234
2016
Q3
$4.09M Sell
55,186
-226
-0.4% -$16.7K 0.12% 194
2016
Q2
$4.06M Sell
55,412
-1,159
-2% -$82.5K 0.12% 199
2016
Q1
$4M Buy
56,571
+9,854
+21% +$656K 0.12% 193
2015
Q4
$3.11M Sell
46,717
-462
-1% -$30.7K 0.09% 251
2015
Q3
$2.99M Sell
47,179
-5,894
-11% -$385K 0.09% 261
2015
Q2
$3.47M Sell
53,073
-816
-2% -$55.4K 0.1% 248
2015
Q1
$3.74M Buy
53,889
+1,426
+3% +$98.6K 0.1% 233
2014
Q4
$3.63M Sell
52,463
-1,299
-2% -$87.7K 0.1% 234
2014
Q3
$3.51M Buy
53,762
+2,833
+6% +$187K 0.1% 237
2014
Q2
$3.47M Sell
50,929
-353
-0.7% -$23.7K 0.1% 241
2014
Q1
$3.33M Sell
51,282
-930
-2% -$58.6K 0.1% 245
2013
Q4
$3.41M Sell
52,212
-223
-0.4% -$14.3K 0.11% 218
2013
Q3
$3.11M Buy
52,435
+275
+0.5% +$16.3K 0.11% 234
2013
Q2
$2.99M Buy
+52,160
New +$3.1M 0.12% 216

Other funds holding CL

Oppenheimer & Co's CL Position: Q1 2026 in Review

Oppenheimer & Co increased its Colgate-Palmolive (CL) stake by 23% in Q1 2026, buying an estimated $888K and bringing the position to 54,209 shares worth $4.62M. The position accounts for 0.06% of the portfolio, ranked #352.

Oppenheimer & Co first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.29M in Q4 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Oppenheimer & Co held 54,209 shares of Colgate-Palmolive worth $4.62M as of Q1 2026.
  • Oppenheimer & Co bought 9,968 Colgate-Palmolive shares in Q1 2026, an estimated $888K.
  • Colgate-Palmolive made up 0.06% of Oppenheimer & Co's portfolio in Q1 2026, its #352 holding.
  • Oppenheimer & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Oppenheimer & Co's Colgate-Palmolive position peaked at $6.29M in Q4 2017.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.